Question

A 66-year-old man with type 2 diabetes and established atherosclerotic cardiovascular disease is on maximum tolerated metformin. His HbA1c is 64 mmol/mol. Which agent should be added to improve glycaemic control and cardiovascular outcomes?

Accepted Answer

SGLT2 inhibitor (e.g., empagliflozin)

Answer

DPP-4 inhibitor (e.g., sitagliptin)

Answer

Basal insulin

Answer

Sulfonylurea (e.g., gliclazide)

Answer

Acarbose

Practice question

A 66-year-old man with type 2 diabetes and established atherosclerotic cardiovascular disease is on maximum tolerated metformin. His HbA1c is 64 mmol/mol. Which agent should be added to improve glycaemic control and cardiovascular outcomes?